| Literature DB >> 26258172 |
Kai Li1, Yang Wang1, Gyongseon Yang2, Sooyoung Byun2, Guodong Rao1, Carolyn Shoen3, Hongliang Yang4, Anmol Gulati1, Dean C Crick4, Michael Cynamon3, Guozhong Huang5, Roberto Docampo5, Joo Hwan No2, Eric Oldfield1.
Abstract
We synthesized a library of 48 analogs of the Mycobacterium tuberculosis cell growth inhibitor SQ109 in which the ethylene diamine linker was replaced by oxa-, thia- or heterocyclic species, and in some cases, the adamantyl group was replaced by a 1,2-carborane or the N-geranyl group by another hydrophobic species. Compounds were tested against Mycobacterium tuberculosis (H37Rv and/or Erdman), Mycobacterium smegmatis, Bacillus subtilis, Escherichia coli, Saccharomyces cerevisiae, Trypanosoma brucei and two human cell lines (human embryonic kidney, HEK293T, and the hepatocellular carcinoma, HepG2). Most potent activity was found against T. brucei, the causative agent of human African trypanosomiasis, and involved targeting of the mitochondrial membrane potential with 15 SQ109 analogs being more active than was SQ109 in cell growth inhibition, having IC50 values as low as 12 nM (5.5 ng/mL) and a selectivity index of ~300.Entities:
Keywords: Tuberculosis; menaquinone; sleeping-sickness; trypanosomes; uncouplers
Year: 2015 PMID: 26258172 PMCID: PMC4527605 DOI: 10.1021/acsinfecdis.5b00026
Source DB: PubMed Journal: ACS Infect Dis ISSN: 2373-8227 Impact factor: 5.084